CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Private Placement, Ordinary Share Offering	Private Placement, Equity Financing Purchase Agreement	Total Pagaya Technologies Ltd. Shareholders’ Equity (Deficit)	Total Pagaya Technologies Ltd. Shareholders’ Equity (Deficit) Private Placement, Ordinary Share Offering	Total Pagaya Technologies Ltd. Shareholders’ Equity (Deficit) Private Placement, Equity Financing Purchase Agreement	Ordinary Shares (Class A and Class B)	Ordinary Shares (Class A and Class B) Private Placement, Ordinary Share Offering	Ordinary Shares (Class A and Class B) Private Placement, Equity Financing Purchase Agreement	Additional Paid-In Capital	Additional Paid-In Capital Private Placement, Ordinary Share Offering	Additional Paid-In Capital Private Placement, Equity Financing Purchase Agreement	Accumulated Other Comprehensive Income (Loss)	Retained Earnings (Accumulated Deficit)	Non-Controlling Interests
Beginning balance (in shares) at Dec. 31, 2023	5,000,000
Beginning balance at Dec. 31, 2023	$ 74,250
Ending balance (in shares) at Mar. 31, 2024	5,000,000
Ending balance at Mar. 31, 2024	$ 74,250
Beginning balance (in shares) at Dec. 31, 2023							62,043,246
Beginning balance at Dec. 31, 2023	665,749			$ 559,721						$ 1,101,914			$ 444	$ (542,637)	$ 106,028
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of ordinary shares upon exercise of share options (in shares)							100,613
Issuance of ordinary shares upon exercise of share options	161			161						161
Issuance of ordinary shares upon vesting of RSUs (in shares)							660,447
Share-based compensation	17,618			17,618						17,618
Issuance of ordinary shares, net of issuance cost and Equity Financing Purchase Agreement (in shares)								7,500,000	298,057
Issuance of ordinary shares, net of issuance cost and Equity Financing Purchase Agreement		$ 89,938	$ 5,338		$ 89,938	$ 5,338					$ 89,938	$ 5,338
Contributions of interests in consolidated VIEs	2,815														2,815
Return of capital to interests in consolidated VIEs	(2,515)														(2,515)
Other comprehensive income (loss)	(21,531)			(24,723)									(24,723)		3,192
Net income (loss)	(31,662)			(21,223)										(21,223)	(10,439)
Ending balance (in shares) at Mar. 31, 2024							70,602,363
Ending balance at Mar. 31, 2024	$ 725,911			626,830						1,214,969			(24,279)	(563,860)	99,081
Beginning balance (in shares) at Dec. 31, 2024	5,000,000
Beginning balance at Dec. 31, 2024	$ 74,250
Ending balance (in shares) at Mar. 31, 2025	5,000,000
Ending balance at Mar. 31, 2025	$ 74,250
Beginning balance (in shares) at Dec. 31, 2024							73,879,982
Beginning balance at Dec. 31, 2024	$ 441,546			326,491						1,282,022			(11,488)	(944,043)	115,055
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of ordinary shares upon exercise of share options (in shares)	376,564						381,271
Issuance of ordinary shares upon exercise of share options	$ 2,267			2,267						2,267
Issuance of ordinary shares upon vesting of RSUs (in shares)							1,113,823
Share-based compensation	14,129			14,129						14,129
Issuance of ordinary shares upon employee stock purchase plan (in shares)							55,876
Issuance of ordinary shares upon employee stock purchase plan	592			592						592
Return of capital to interests in consolidated VIEs	(4,439)														(4,439)
Other comprehensive income (loss)	(15,784)			(15,882)									(15,882)		98
Net income (loss)	2,492			7,893										7,893	(5,401)
Ending balance (in shares) at Mar. 31, 2025							75,430,952
Ending balance at Mar. 31, 2025	$ 440,803			$ 335,490						$ 1,299,010			$ (27,370)	$ (936,150)	$ 105,313